TuHURA Biosciences Inc (HURA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $84.76M
Last updated: Nov 17, 2026 at 4:26 PM ET
TuHURA Biosciences Inc (HURA) Statistics
TuHURA Biosciences (HURA) has a market cap of $84.76M and an enterprise value of $92.40M. Its share count is up 28.29% from a year earlier.
Total Valuation
Enterprise value is 9.02% above the market cap, as debt exceeds cash.
| Market Cap | $84.76M |
|---|---|
| Enterprise Value | $92.40M |
| Latest price (Nov 17, 2026) | $1.40 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 13, 2026 |
| Fiscal Year End | June |
Price Statistics
The stock is down 31.71% over 52 weeks and trades 25.93% below its 50-day average.
| Beta (1Y) | 2.82 |
|---|---|
| 52-Week Change | -31.71% |
| 1-Month Change | -21.35% |
| 3-Month Change | -38.60% |
| 6-Month Change | -43.09% |
| 5-Year Change | -99.87% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -31.71% |
| Total Return (3Y CAGR) | -52.18% |
| Total Return (5Y CAGR) | -74.78% |
| Return vs SPY (1Y) | -39.02% |
| Max Drawdown (1Y) | -78.95% |
| Max Drawdown (3Y) | -96.82% |
| Sharpe Ratio (1Y) | -0.26 |
| Correlation with SPY (1Y) | 0.31 |
| 50-Day Average | $1.89 |
| 200-Day Average | $2.03 |
| 52-Week Range | $0.41 to $3.43 |
| RSI (14 Days) | 34.6 |
| Average Volume (20 Days) | 601.32K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.47x current liabilities, and total debt is 0.50x shareholder equity.
| Current Ratio | 0.47x |
|---|---|
| Quick Ratio | 0.47x |
| Debt / Equity | 0.50x |
| Interest Coverage | -15.12x |
Returns and Efficiency
Return on invested capital is -77.84% and return on equity is -157.96% over the last 12 months.
| Return on Equity (ROE) | -157.96% |
|---|---|
| Return on Assets (ROA) | -82.61% |
| Return on Invested Capital (ROIC) | -77.84% |
| Return on Capital Employed (ROCE) | -98.55% |
Scores
HURA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$30.13M |
| Pretax Income | -$29.93M |
| Net Income | -$29.94M |
| EBITDA | -$27.97M |
| EBIT | -$28.07M |
| Reported EPS (TTM) | -$0.53 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 52.29% of the $36.24M in total assets.
| Cash and Equivalents | $1.89M |
|---|---|
| Total Debt | $9.54M |
| Net Debt | $7.65M |
| Net Debt Per Share | $0.12 |
| Working Capital | -$4.07M |
| Shareholder Equity | $18.95M |
| Book Value Per Share | $0.29 |
| Tangible Book Value | -$3.06M |
| Total Assets | $36.24M |
| Total Liabilities | $17.29M |
Balance sheet as of Sep 30, 2026.
Stock Splits
The last split was a 1-for-35 reverse split on Oct 18, 2024.
| Last Split Date | Oct 18, 2024 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:35 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About HURA
What is HURA's market cap?
TuHURA Biosciences has a market cap of $84.76M. Its enterprise value, which adds debt and subtracts cash, is $92.40M.
How many shares of HURA are outstanding?
TuHURA Biosciences has 65.00M shares outstanding. The count is up 28.29% from a year earlier.
Does HURA pay a dividend?
No. TuHURA Biosciences does not pay a dividend.
How much debt does HURA have?
TuHURA Biosciences has $9.54M of total debt and $1.89M of cash and equivalents, a net debt position of $7.65M.
HURA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors